# Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

> **NCT05001945** · PHASE2 · COMPLETED · sponsor: **Mineralys Therapeutics Inc.** · enrollment: 200 (actual)

## Conditions studied

- Hypertension, Renal

## Interventions

- **DRUG:** MLS-101 (Part I)
- **OTHER:** Placebo (Part I)
- **OTHER:** Placebo (Part II)
- **DRUG:** MLS-101 (Part II)

## Key facts

- **NCT ID:** NCT05001945
- **Lead sponsor:** Mineralys Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2022-09-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05001945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05001945, "Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05001945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*